Edaglitazone
Alternative Names: edaglitazone sodium; R483; RO2052349-602Latest Information Update: 18 May 2006
At a glance
- Originator Chugai Pharmaceutical; Roche
- Developer Roche
- Class Antihyperglycaemics; Small molecules; Thiazolidinediones
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 26 Apr 2006 Discontinued - Phase-I for Type-2 diabetes mellitus in Japan (PO)
- 26 Apr 2006 Discontinued - Phase-II for Type-2 diabetes mellitus in Eastern Europe (PO)
- 26 Apr 2006 Discontinued - Phase-II for Type-2 diabetes mellitus in Mexico (PO)